植え込み型心臓リズム管理装置の世界市場レポート 2025年

植え込み型心臓リズム管理装置の市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は6.8%で、232億7,000万米ドルに成長します。予測期間の成長は、リードレス装置へのシフト、患者の遠隔モニタリング、心不全管理への注力、新興市場での採用拡大、研究開発のための共同開発などに起因すると考えられます。予測期間の主な動向には、生体吸収性技術の登場、人工知能（AI）の統合、技術の進歩、遠隔モニタリングと遠隔医療の統合、リードレスペースメーカーの進歩、ワイヤレス充電、電力管理などがあります。

心臓疾患の罹患率の上昇は、植え込み型心臓リズム管理装置市場の成長を著しく高めると予測されています。心臓疾患とは、心臓や血管に影響を及ぼす状態を指します。植え込み型心臓リズム管理装置は、心臓収縮の再同期化を通じて収縮機能を改善し、生命を脅かす急速な心室性不整脈の際に正常なリズムを回復させることで、心不全や左心室機能低下の患者を支援するように設計されています。その結果、心臓疾患の有病率の増加がこれらの機器の需要を牽引することになります。例えば、2024年9月、英国を拠点とする心臓血管研究慈善団体British Heart Foundationのデータから、英国では約760万人が心臓および循環器疾患に罹患していることが明らかになりました。このうち、男性約400万人、女性約360万人がこれらの疾患に罹患しており、英国における全死亡者の約27％を占め、毎年17万人以上が死亡していることになります。したがって、心臓疾患の有病率の増加は、植え込み型心臓リズム管理装置市場の成長を促進する重要な要因となっています。

高齢化人口の増加は、今後数年間、植え込み型心臓リズム管理装置市場の成長を大きく促進すると予想されます。高齢化とは、国民のかなりの部分が高齢化し、住民の平均年齢が高くなる人口動態を指します。植え込み型心臓リズム管理装置は、心臓に関連するさまざまな問題に対処・管理するために、この層で頻繁に利用されています。たとえば、米国の非営利団体である人口問題研究所は、2024年1月、65歳以上の米国人の数が2022年の5,800万人から2050年には8,200万人になり、47％増加すると予測しています。さらに、この年齢層が総人口に占める割合は、同じ期間に17％から23％に増加すると予想されています。その結果、高齢化人口の拡大が植え込み型心臓リズム管理装置市場の成長を促進する重要な要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の植え込み型心臓リズム管理装置市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の植え込み型心臓リズム管理装置市場：成長率分析
• 世界の植え込み型心臓リズム管理装置市場の実績：規模と成長、2019～2024年
• 世界の植え込み型心臓リズム管理装置市場の予測：規模と成長、2024～2029年、2034年
• 世界の植え込み型心臓リズム管理装置総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の植え込み型心臓リズム管理装置市場：デバイス別、実績と予測、2019～2024年、2024～2029年、2034年
• 心臓再同期療法
• 除細動器
• ペースメーカー
• 世界の植え込み型心臓リズム管理装置市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 徐脈
• 頻脈
• その他
• 世界の植え込み型心臓リズム管理装置市場：最終用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• 専門心臓センター
• その他
• 世界の植え込み型心臓リズム管理装置市場：心臓再同期療法（CRT）のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• CRT-P（ペースメーカー）
• CRT-D（除細動器）
• 世界の植え込み型心臓リズム管理装置市場：除細動器のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 植え込み型除細動器（ICD）
• 皮下植え込み型除細動器（S-ICD）
• 世界の植え込み型心臓リズム管理装置市場：ペースメーカーのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 単腔ペースメーカー
• 二腔ペースメーカー
• 両室ペースメーカー

第7章 地域別・国別分析

• 世界の植え込み型心臓リズム管理装置市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の植え込み型心臓リズム管理装置市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 植え込み型心臓リズム管理装置市場：競合情勢
• 植え込み型心臓リズム管理装置市場：企業プロファイル
  • Schiller AG Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Zoll Medical Corporation
• Biotronik Ltd.
• MicroPort Scientific Corporation
• Abiomed Inc
• Nihon Kohden Corporation
• Japan Lifeline Co. Ltd.
• Lepu Medical Technology Co. Ltd.
• LivaNova PLC
• Shenzhen Mindray Biomedical Electronics Co. Ltd
• Progetti Srl
• Edwards Lifesciences Corporation
• Cardiac Science Corporation
• Bardy Diagnostics Inc.
• Beijing Demax Medical Technology Co. Ltd
• iRhythm Technologies Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 植え込み型心臓リズム管理装置市場2029年：新たな機会を提供する国
• 植え込み型心臓リズム管理装置市場2029年：新たな機会を提供するセグメント
• 植え込み型心臓リズム管理装置市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Implantable cardiac rhythm management devices are small battery-operated devices that are surgically inserted inside the body and connected to the heart, playing a crucial role in maintaining and managing heart rhythm.

The primary devices in the category of implantable cardiac rhythm management devices include cardiac resynchronization therapy, defibrillators, and pacemakers. Cardiac resynchronization therapy (CRT) is a specialized treatment designed for severe cardiac rhythm issues. These devices find applications in various conditions such as bradycardia, tachycardia, and others, and are utilized in hospitals, specialty cardiac centers, and other medical settings.

The implantable cardiac rhythm management device market research report is one of a series of new reports from The Business Research Company that provides implantable cardiac rhythm management device market statistics, including implantable cardiac rhythm management device industry global market size, regional shares, competitors with implantable cardiac rhythm management device market share, detailed implantable cardiac rhythm management device market segments, market trends, and opportunities, and any further data you may need to thrive in the implantable cardiac rhythm management device industry. This implantable cardiac rhythm management device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The implantable cardiac rhythm management device market size has grown steadily in recent years. It will grow from$17.06 billion in 2024 to $17.87 billion in 2025 at a compound annual growth rate (CAGR) of 4.8%. The growth in the historic period can be attributed to the aging population, increasing incidence of cardiac arrhythmias, awareness and education initiatives, healthcare infrastructure development, and rising healthcare expenditure

The implantable cardiac rhythm management device market size is expected to see strong growth in the next few years. It will grow to $23.27 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to a shift towards leadless devices, remote patient monitoring, a focus on heart failure management, increased adoption in emerging markets, and collaborations for research and development. Major trends in the forecast period include the emergence of bioresorbable technologies, integration of artificial intelligence (AI), advancements in technology, remote monitoring and telemedicine integration, advancements in leadless pacemakers, wireless charging, and power management.

The rising incidence of cardiac disorders is anticipated to significantly enhance the growth of the implantable cardiac rhythm management devices market. Cardiac disorders refer to conditions that impact the heart or blood vessels. Implantable cardiac rhythm management devices are designed to assist patients with heart failure and diminished left ventricular function by improving systolic function through the resynchronization of heart contractions and restoring normal rhythm during life-threatening rapid ventricular arrhythmias. As a result, the growing prevalence of cardiac disorders will drive demand for these devices. For instance, in September 2024, data from the British Heart Foundation, a UK-based cardiovascular research charity, revealed that approximately 7.6 million individuals in the UK are affected by heart and circulatory diseases. This includes about 4 million men and 3.6 million women living with these conditions, which account for roughly 27% of all deaths in the UK, translating to over 170,000 fatalities each year, or about 480 deaths per day-equivalent to one death every three minutes. Therefore, the increasing prevalence of cardiac disorders is a key factor propelling the growth of the implantable cardiac rhythm management devices market.

The growing aging population is anticipated to significantly drive the growth of the implantable cardiac rhythm management devices market in the coming years. An aging population refers to a demographic trend where a significant portion of a country's citizens are becoming older, leading to a higher average age among its residents. Implantable cardiac rhythm management devices are frequently utilized within this demographic to address and manage various heart-related issues. For example, in January 2024, the Population Reference Bureau, a US-based nonprofit organization, projected that the number of Americans aged 65 and older will rise from 58 million in 2022 to 82 million by 2050, marking a 47% increase. Additionally, this age group's proportion of the total population is expected to increase from 17% to 23% over the same period. Consequently, the expanding aging population is a key factor propelling the growth of the implantable cardiac rhythm management devices market.

Technological advancement stands out as a prominent trend in the implantable cardiac rhythm management devices market, with major companies focusing on developing innovative technologies to maintain their market position. Rhythm Management Group PLLC, a US-based company, introduced RhythmSynergy in April 2022, a technology platform that utilizes machine learning to deliver timely clinical insights for patients monitored remotely with implantable cardiac devices and wearable devices. This platform streamlines the review processes by combining clinical knowledge and machine learning technologies, making it simpler to review, share, and analyze patient data.

Major companies in the implantable cardiac rhythm management devices market prioritize the launch of innovative products such as implantable cardiac defibrillators. In October 2023, MicroPort CRM, a France-based manufacturer, launched the ULYS Implantable Cardioverter Defibrillator (ICDs) and INVICTA defibrillation implantable devices. The ULYS ICD integrates cutting-edge technology with minimal energy consumption, featuring the AutoMRI function and PARAD arrhythmia discrimination algorithm. The INVICTA defibrillation lead consistently senses electrical signals from the right ventricle, providing pacing therapy if the heart rate is too low.

In August 2022, Medtronic, a US-based medical technology company, completed the acquisition of Affera Inc. for an undisclosed amount. This acquisition grants Medtronic access to the Affera Prism-1TM cardiac mapping and navigation platform, compatible with both Medtronic therapeutic catheters and various competing technologies. Affera Inc., a US-based medical technology company, specializes in manufacturing cardiac mapping and navigation systems for treating patients with cardiac arrhythmias.

Major companies operating in the implantable cardiac rhythm management device market include Schiller AG, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Koninklijke Philips N.V., Zoll Medical Corporation, Biotronik Ltd., MicroPort Scientific Corporation, Abiomed Inc, Nihon Kohden Corporation, Japan Lifeline Co. Ltd., Lepu Medical Technology Co. Ltd., LivaNova PLC, Shenzhen Mindray Biomedical Electronics Co. Ltd, Progetti Srl, Edwards Lifesciences Corporation, Cardiac Science Corporation, Bardy Diagnostics Inc., Beijing Demax Medical Technology Co. Ltd, iRhythm Technologies Inc., Impulse Dynamics plc., VytronUS Inc.

North America was the largest region in the implantable cardiac rhythm management device market in 2024. The regions covered in the implantable cardiac rhythm management device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the implantable cardiac rhythm management device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The implantable cardiac rhythm management devices market consists of sales of the leadless pacemaker, insertable cardiac monitor, cardiac leads, and subcutaneous implantable defibrillator (S-ICD). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Cardiac Rhythm Management Device Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable cardiac rhythm management device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable cardiac rhythm management device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The implantable cardiac rhythm management device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Device: Cardiac Resynchronization Therapy; Defibrillators; Pacemakers
• 2) By Application: Bradycardia; Tachycardia; Other Applications
• 3) By End-Use: Hospitals; Specialty Cardiac Centers; Other End-Uses
• Subsegments:
• 1) By Cardiac Resynchronization Therapy (CRT): CRT-P (Pacemaker); CRT-D (Defibrillator)
• 2) By Defibrillators: Implantable Cardioverter Defibrillators (ICDs); Subcutaneous Implantable Defibrillators (S-ICDs)
• 3) By Pacemakers: Single-Chamber Pacemakers; Dual-Chamber Pacemakers; Biventricular Pacemakers
• Companies Mentioned: Schiller AG; Medtronic plc; Abbott Laboratories; Boston Scientific Corporation; Koninklijke Philips N.V.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Implantable Cardiac Rhythm Management Device Market Characteristics

3. Implantable Cardiac Rhythm Management Device Market Trends And Strategies

4. Implantable Cardiac Rhythm Management Device Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Implantable Cardiac Rhythm Management Device Growth Analysis And Strategic Analysis Framework

• 5.1. Global Implantable Cardiac Rhythm Management Device PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Implantable Cardiac Rhythm Management Device Market Growth Rate Analysis
• 5.4. Global Implantable Cardiac Rhythm Management Device Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Implantable Cardiac Rhythm Management Device Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Implantable Cardiac Rhythm Management Device Total Addressable Market (TAM)

6. Implantable Cardiac Rhythm Management Device Market Segmentation

• 6.1. Global Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiac Resynchronization Therapy
• Defibrillators
• Pacemakers
• 6.2. Global Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bradycardia
• Tachycardia
• Other Applications
• 6.3. Global Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Cardiac Centers
• Other End-Uses
• 6.4. Global Implantable Cardiac Rhythm Management Device Market, Sub-Segmentation Of Cardiac Resynchronization Therapy (CRT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CRT-P (Pacemaker)
• CRT-D (Defibrillator)
• 6.5. Global Implantable Cardiac Rhythm Management Device Market, Sub-Segmentation Of Defibrillators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Implantable Cardioverter Defibrillators (ICDs)
• Subcutaneous Implantable Defibrillators (S-ICDs)
• 6.6. Global Implantable Cardiac Rhythm Management Device Market, Sub-Segmentation Of Pacemakers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Chamber Pacemakers
• Dual-Chamber Pacemakers
• Biventricular Pacemakers

7. Implantable Cardiac Rhythm Management Device Market Regional And Country Analysis

• 7.1. Global Implantable Cardiac Rhythm Management Device Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Implantable Cardiac Rhythm Management Device Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Implantable Cardiac Rhythm Management Device Market

• 8.1. Asia-Pacific Implantable Cardiac Rhythm Management Device Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Implantable Cardiac Rhythm Management Device Market

• 9.1. China Implantable Cardiac Rhythm Management Device Market Overview
• 9.2. China Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Implantable Cardiac Rhythm Management Device Market

• 10.1. India Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Implantable Cardiac Rhythm Management Device Market

• 11.1. Japan Implantable Cardiac Rhythm Management Device Market Overview
• 11.2. Japan Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Implantable Cardiac Rhythm Management Device Market

• 12.1. Australia Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Implantable Cardiac Rhythm Management Device Market

• 13.1. Indonesia Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Implantable Cardiac Rhythm Management Device Market

• 14.1. South Korea Implantable Cardiac Rhythm Management Device Market Overview
• 14.2. South Korea Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Implantable Cardiac Rhythm Management Device Market

• 15.1. Western Europe Implantable Cardiac Rhythm Management Device Market Overview
• 15.2. Western Europe Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Implantable Cardiac Rhythm Management Device Market

• 16.1. UK Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Implantable Cardiac Rhythm Management Device Market

• 17.1. Germany Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Implantable Cardiac Rhythm Management Device Market

• 18.1. France Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Implantable Cardiac Rhythm Management Device Market

• 19.1. Italy Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Implantable Cardiac Rhythm Management Device Market

• 20.1. Spain Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Implantable Cardiac Rhythm Management Device Market

• 21.1. Eastern Europe Implantable Cardiac Rhythm Management Device Market Overview
• 21.2. Eastern Europe Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Implantable Cardiac Rhythm Management Device Market

• 22.1. Russia Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Implantable Cardiac Rhythm Management Device Market

• 23.1. North America Implantable Cardiac Rhythm Management Device Market Overview
• 23.2. North America Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Implantable Cardiac Rhythm Management Device Market

• 24.1. USA Implantable Cardiac Rhythm Management Device Market Overview
• 24.2. USA Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Implantable Cardiac Rhythm Management Device Market

• 25.1. Canada Implantable Cardiac Rhythm Management Device Market Overview
• 25.2. Canada Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Implantable Cardiac Rhythm Management Device Market

• 26.1. South America Implantable Cardiac Rhythm Management Device Market Overview
• 26.2. South America Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Implantable Cardiac Rhythm Management Device Market

• 27.1. Brazil Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Implantable Cardiac Rhythm Management Device Market

• 28.1. Middle East Implantable Cardiac Rhythm Management Device Market Overview
• 28.2. Middle East Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Implantable Cardiac Rhythm Management Device Market

• 29.1. Africa Implantable Cardiac Rhythm Management Device Market Overview
• 29.2. Africa Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Implantable Cardiac Rhythm Management Device Market Competitive Landscape And Company Profiles

• 30.1. Implantable Cardiac Rhythm Management Device Market Competitive Landscape
• 30.2. Implantable Cardiac Rhythm Management Device Market Company Profiles
  • 30.2.1. Schiller AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis

31. Implantable Cardiac Rhythm Management Device Market Other Major And Innovative Companies

• 31.1. Zoll Medical Corporation
• 31.2. Biotronik Ltd.
• 31.3. MicroPort Scientific Corporation
• 31.4. Abiomed Inc
• 31.5. Nihon Kohden Corporation
• 31.6. Japan Lifeline Co. Ltd.
• 31.7. Lepu Medical Technology Co. Ltd.
• 31.8. LivaNova PLC
• 31.9. Shenzhen Mindray Biomedical Electronics Co. Ltd
• 31.10. Progetti Srl
• 31.11. Edwards Lifesciences Corporation
• 31.12. Cardiac Science Corporation
• 31.13. Bardy Diagnostics Inc.
• 31.14. Beijing Demax Medical Technology Co. Ltd
• 31.15. iRhythm Technologies Inc.

32. Global Implantable Cardiac Rhythm Management Device Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Implantable Cardiac Rhythm Management Device Market

34. Recent Developments In The Implantable Cardiac Rhythm Management Device Market

35. Implantable Cardiac Rhythm Management Device Market High Potential Countries, Segments and Strategies

• 35.1 Implantable Cardiac Rhythm Management Device Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Implantable Cardiac Rhythm Management Device Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Implantable Cardiac Rhythm Management Device Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer